Pure Global AI
Disease / condition

Pulmonary Arterial Hypertension clinical trials

Free access to 389 studies10+ countriesUpdated daily62 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
389
Total trials
10+
Countries
10+
Sponsors
62
Recruiting
By phase
N/A154
Phase 271
Phase 363
Phase 145
Phase 441
By status
Completed185
Recruiting62
Terminated45
Unknown33
Not yet recruit...26
Top countries
United States of America105
China16
France11
Canada11
Australia9
Top sponsors
Actelion46
United Therapeutic...31
Novartis Pharmaceu...10
Pfizer's Upjohn ha...10
Bial - Portela C S...9
Recent trials
Latest clinical trials for Pulmonary Arterial Hypertension
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension
Mayo Clinic · United States of America
NCT06409026Not yet recr...
Phase
Phase 4
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
AOP Orphan Pharmaceuticals AG · Austria,France,Hungary,Spain
NCT06350032Not yet recr...
Phase
Phase 3
Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension
Cereno Scientific AB · Sweden
NCT06321705Available
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
AOP Orphan Pharmaceuticals AG · Austria,Czech,France,Germany,Hungary,Italy,Poland,Portugal,Romania,Spain
NCT06317805Recruiting
Phase
Phase 4
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
GB002, Inc. · United States of America
NCT06274801Not yet recr...
Phase
Phase 3
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Pfizer
NCT06137742Not yet recr...
Phase
Phase 1
Safety and Efficacy of BIA 5-1058 in PAH
Bial - Portela C S.A. · Austria,Germany,Italy,Portugal,Spain,United Kingdom
NCT06009185Completed
Phase
Phase 2
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).
Keros Therapeutics, Inc. · Australia
NCT05975905Recruiting
Phase
Phase 2
Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients
Riphah International Universit... · Pakistan
NCT05947032Not yet recr...
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
Shape Medical Systems, Inc. · United States of America
NCT05977933Not yet recr...
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
GB002, Inc. · United States of America
NCT05934526Not yet recr...
Phase
Phase 3
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
Vigonvita Life Sciences · China
NCT05948644Completed
Phase
Phase 1
Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults
Pharmosa Biopharm Inc. · Australia
NCT05938946Not yet recr...
Phase
Phase 1
A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)
Merck Sharp & Dohme LLC · Japan
NCT05818137Recruiting
Phase
Phase 3
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Sheffield Teaching Hospitals N...
NCT05825417Not yet recr...
Phase
Phase 4
Untitled Trial
Insmed Godo Kaisha · United States of America;Argentina;Australia;Mexico;Phillipines;Austria;Belgium;Brazil;Denmark;Germa
jRCT2061220089Recruiting
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Novartis Pharmaceuticals · Germany,Poland
NCT05764265Recruiting
Phase
Phase 2
A Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Insmed Incorporated · Japan
NCT05649748Recruiting
Phase
Phase 2/3
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
International University of He... · Japan
NCT05679570Recruiting
Phase
Phase 2
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets
Guangzhou Magpie Pharmaceutica...
NCT05660863Not yet recr...
Phase
Phase 1
View all 389 trials →
About this profile

Access comprehensive clinical trial information for Pulmonary Arterial Hypertension through Pure Global AI's free database. This collection includes 389 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 62 trials are actively recruiting participants.

Research for Pulmonary Arterial Hypertension is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Actelion and United Therapeutics. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 389 clinical trials studying Pulmonary Arterial Hypertension, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Actelion, United Therapeutics, Novartis Pharmaceuticals, among others.